Process Development of Halaven®: Synthesis of the C1-C13 Fragment from d-(-)-Gulono-1,4-lactone

Abstract

A 12-step kilogram-scale synthesis of the C1–C13 fragment, common to halichondrin B and the totally synthetic analogue Halaven® (E7389, INN eribulin mesylate), is described. The synthesis features four crystalline intermediates which facilitates throughput, and enhances quality control of all stereogenic centers in the title compound.